Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 15, 2019 at 9:30 AM

    NEXT STORY
    American Gene Technologies to Present at 2019 Cell & Gene Meeting on the Mesa
    PREV STORY
    Single-Inhaler Extrafine Triple Therapy of Inhaled Corticosteroid, Long-Acting B2-Agonist and Long-Acting Muscarinic Antagonist Therapy Improves Lung Function and Reduces Asthma Exacerbations(1)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Madrigal Pharmaceuticals Announces Completion of Enrollment in Phase 3 MAESTRO NAFLD-1 Trial and Reports 2020 Third Quarter Financial Results and Highlights

    author_avatar
    NASDAQ Market News

    Immunomedics to Present at Jefferies 2016 Global Healthcare Conference

    MORRIS PLAINS, N.J., June 07, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today  announced ...

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Announces First Quarter 2018 Financial Results and Business Update Conference Call on May 30

    COPENHAGEN, Denmark, May 16, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company ...

    author_avatar
    NASDAQ Market News